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ABSTRACT
Objective: People who spend a longer time walking
have lower demands for medical care. However, in
view of their longer life expectancy, it is unclear
whether their lifetime medical expenditure increases or
decreases. The present study examined the
association between time spent walking, life
expectancy and lifetime medical expenditure.
Method: The authors followed up 27738 participants
aged 40e79 years and prospectively collected data on
their medical expenditure and survival covering
a 13-year-period. Participants were classiﬁed into
those walking <1 and $1 h per day. The authors
constructed life tables and estimated the life
expectancy and lifetime medical expenditure from
40 years of age using estimate of multiadjusted
mortality and medical expenditure using a Poisson
regression model and linear regression model,
respectively.
Results: Participants who walked $1 h per day have
a longer life expectancy from 40 years of age than
participants who walked <1 h per day. The multiadjusted
life expectancy for those who walked $1hp e rd a yw a s
44.81 years, signiﬁcantly lower by 1.38 years in men
(p¼0.0073) in men and 57.78 years in women,
non-signiﬁcantly lower by 1.16 years in women
(p¼0.2351). In addition to their longer life expectancy,
participants who walked $1 h per day required a lower
lifetime medical expenditure from 40 years of age than
participants who walked <1 h per day. The multiadjusted
lifetime medical expenditure for those who walked $1h
per day was £99423.6, signiﬁcantly lower by 7.6% in
men (p¼0.0048) and £128161.2, non-signiﬁcantly lower
by 2.7% in women (p¼0.2559).
Discussion: Increased longevity resulting from
a healthier lifestyle does not necessarily translate into
an increased amount of medical expenditure
throughout life. Encouraging people to walk may
extend life expectancy and decrease lifetime medical
expenditure, especially for men.
INTRODUCTION
Previous studies have agreed that a higher
level of physical activity extends life expect-
ancy.
1e4 Walking is part of a physically active
lifestyle. Previous studies have indicated that
a longer time spent walking,
5e13 walking
pace
81 4 e16 and a longer distance walked
17 18
are signiﬁcantly associated with a decreased
risk of mortality.
We previously reported that medical
expenditure per month was signiﬁcantly
reduced among those who spent a longer
time walking, based on the same cohort
dataset as that used here.
19 Similar ﬁndings
have been reported worldwide.
20 21 However,
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ARTICLE SUMMARY
Article focus
- Medical expenditure per month was reduced
when the amount of time spent walking was
increased.
- Walking is associated with a decreased risk of
mortality.
- In view of the increased life expectancy of those
who walk longer, it is unclear whether lifetime
medical expenditure increases or decreases as
a result.
Key messages
- Lifetime medical expenditure from the age of
40 years for men and women who walked $1h
per day was reduced by 7.6% and 2.7%,
respectively, in comparison with those who
walked <1 h per day.
- Years of life added as a result of a healthy
lifestyle did not necessarily translate into
an increased amount of lifetime medical
expenditure.
Strengths and limitations of this study
- This is the ﬁrst study to investigate the
association between walking, life expectancy
and lifetime medical expenditure.
- We assessed walking using a simple question-
naire, in which we asked the participants to
report only the time spent walking, and did not
ask about walking pace, distance walked or any
distinction between walking for exercise and
other reasons.
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Open Access Researchin view of the increased life expectancy of those who
walk for a longer time, it is unclear whether lifetime
medical expenditure increases or decreases as a result.
In other words, the question to be answered here is
whether a lifelong healthy lifestyle eventually increases
lifetime medical expenditure because of extended life
expectancy.
So far, only one study has examined the association
between physical activity and lifetime costs.
4 This
revealed that people with a high physical activity level
tended to live longer than people with a lower physical
activity level, and that the former had lower lifetime
medical costs than the latter. However, that study was
only a simulation analysis based on assumed variations in
the health and economic effects of active and sedentary
lifestyles.
The objective of the present study was to examine the
association between walking, life expectancy and lifetime
medical expenditure using actual individual data derived
from a population-based 13-year prospective observation
period. The population comprised 27738 Japanese
adults aged 40e79 years living in the community who
were free of any functional limitations or chronic
conditions interfering with physical activity, with an
accrued total of 285342 person-years. This cohort study
has been monitoring survival and medical care utilisa-
tion, and its costs, for all participants.
19 22 Using this
dataset, we constructed a life table to estimate life
expectancy and lifetime medical expenditure according
to the time spent walking.
24 25
MATERIALS AND METHODS
Study cohort
The present data were derived from the Ohsaki National
Health Insurance (NHI) Cohort Study.
19 22 25 We
conducted a self-administered questionnaire survey of
various lifestyle habits between October and December
1994 for all NHI beneﬁciaries aged 40e79 years who
lived in the catchment area of Ohsaki Public Health
Center, Miyagi Prefecture, northeastern Japan. Out of
54996 eligible individuals, 52029 (95%) responded.
We excluded 776 participants who had withdrawn
from the NHI before 1 January 1995 because their cost
data were not available. Thus, the remaining 51253
participants formed the study cohort. The study protocol
was approved by the Ethics Committee of Tohoku
University School of Medicine. Participants who had
returned the self-administered questionnaires and
signed them were considered to have consented to
participate.
For the present analysis, we excluded participants who
had functional limitation or chronic conditions inter-
fering with physical activity. Physical function status was
assessed using the six-item measure of the Medical
Outcomes Study Short-form General Health Survey.
26
Participants were excluded if they stated on the Medical
Outcomes Study questionnaire that they were unable to
perform moderate or vigorous activities (n¼15916). We
excluded participants who reported severe bodily pain
(n¼949), or any history of stroke (n¼474), myocardial
infarction (n¼585) or arthritis (n¼2176). We also
excluded those who died within the ﬁrst year (n¼174) or
did not provide complete responses in the walking status
questionnaire (n¼3241). Thus, a total of 27738 partici-
pants (15521 men and 12217 women) remained. These
participants were apparently healthy enough to walk for
as long as they wished.
Time spent walking
The self-administered questionnaire included items on
time spent walking. Time spent walking was assessed
through the subject’s response to the question, ‘About
how much time do you walk per day on average?’ The
participants were asked to choose one of three answers:
‘1 h or more,’ ‘30 mind1 h’ or ‘30 min or less.’ In Japan,
the Ministry of Health, Labour and Welfare recom-
mended to walk $1 h per day in Exercise and Physical
Activity Reference for Health Promotion 2006. Then, we
divided the participants into two groups according to the
time spent walking daily: <1 h and $1 h. We had previ-
ously evaluated and reported the validity of self-reported
time spent walking.
5 19 27 This validation study had
indicated that self-reported walking time was reasonably
reproducible and sufﬁciently valid for studying the
health effects of walking.
Health-insurance system in Japan
Details of the Japanese NHI system have been described
previously.
22 28 29 Brieﬂy, everyone living in Japan is
required to enrol in a health-insurance system. The NHI
covers 35% of the Japanese population, mainly farmers,
self employed or retired people. The NHI covers almost
all medical treatment, including diagnostic tests, medi-
cation, surgery, supplies and materials, physicians and
other personnel costs, inpatient care and most dental
treatment. It covers treatment by physicians and nurses
but not that by other professionals such as home health
aides. Payment to medical providers is made on a fee-
for-service basis, where the price of each service is
determined by a uniform national fee schedule.
When a participant withdraws from the NHI system
because of death, emigration or employment, the with-
drawal date and its reason are coded in the NHI with-
drawal history ﬁles. We recorded any mortality or
migration by reviewing the NHI withdrawal history ﬁles
and collected data on the death of participants by
reviewing the death certiﬁcates ﬁled at Ohsaki Public
Health Center. We thus followed up the participants and
prospectively collected data on medical care utilisation
and its costs for all individuals in the cohort from
1 January 1995 to 31 December 2007. Study participants
(16.3%) were lost to follow-up, so their vital status was
unknown.
Statistical analysis
Using the Ohsaki NHI cohort database, we estimated
mortality and medical expenditure for individual age
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both men and women. We divided age into the following
groups: 40e44, 45e49, 50e54, 55e59, 60e64, 65e69,
70e74, 75e79, 80e84 and $85 years. The multiadjusted
mortalities for each age category were estimated from
a Poisson regression model based on person-years and
the number of deaths from 1996 until 2007. The
dependent variable was mortality, and the independent
variables were age groups, categories of time spent
walking and the following covariates: smoking status
(current and past smoker, or never smoker), alcohol
consumption (current drinker consuming 1e499 g/
week, current drinker consuming $450 g/week, or
never and past drinker), body mass index (BMI:
<21 kg/m
2,2 1 e24.9 kg/m
2 or $25 kg/m
2), self-rated
health (good or not good), sports and physical activity
($3h / w e e k o r <3h / w e e k ) , h i s t o r y o f h y p e r t e n s i o n
disease (presence or absence), history of diabetes
mellitus (presence or absence), history of cancer
(presence or absence), history of liver disease (pres-
ence or absence) and history of kidney disease (pres-
ence or absence).
19 The data on all covariates were
obtained from a self-administered questionnaire. We
estimated the mortality of participants aged $85 years
by multiplying the estimated mortality for the 85e89-
year age group by the ratio of mortality for the same age
group relative to the mortality for $85 years from
complete life tables for the year 2000, as there were few
person-years for participants aged over 90 years in our
dataset.
30
Because medical expenditure increases before death,
we separately calculated medical expenditure for
participants who survived through the index year and for
those who died. The multiadjusted medical expenditure
per year for survivors and decedents, respectively, was
estimated for each of the age groups and the categories
of time spent walking using a linear regression model
adjusted for the above covariates.
The estimates of multiadjusted mortality and medical
expenditure for each age group were used for esti-
mating life expectancy and lifetime medical expendi-
ture from 40 years of age. Life expectancy was
calculated using Chiang’s analytical method on the
basis of the latest published complete life tables of
Japan for the year 2000.
23 30 Lifetime medical expen-
diture was estimated from the sum obtained by multi-
plying the static population in life table by the medical
expenditure for survivors and the number of deaths in
the life table by the increased medical expenditure
owing to death, which was calculated by subtracting the
medical expenditure in year of survivors from that in
the period of 1 year before death. That is, the life
expectancy (ex) and lifetime medical expenditure (Me)
for each age group (x) were estimated using the
numbers of survivors (lx), deaths (dx), static population
(Lx), multiadjusted medical expenditure for survivors
(ay) and multiadjusted medical expenditure for the
deceased (by) as follows:
+ is the sum of y$x
ex ¼
+Ly
lx
Mx ¼
+

Lyayþdyby

lx
The 95% CIs were estimated using a Monte Carlo
simulation with 100 000 replicates based on a Poisson
regression model and linear regression model. All
analyses were used the SAS V.9.1 statistical software
package.
We used a purchasing-power parity rate (British
pounds to Japanese yen) of £1.00¼U140.
RESULTS
After 13 years of follow-up, we observed 2936 deaths
(2193 men and 743 women) among the 27738 partici-
pants (15521 men and 12217 women). The mean
medical expenditure per year for survivors who walked
$1 h per day was £1714.2 in men and £1621.4 in women,
signiﬁcantly lower than for those who walked <1 h per
day (men: £2064.3, p<0.0001; women: £1878.6,
p<0.0001). Also, the mean medical expenditure in the
year of death for participants who walked $1 h per day
was £16878.6 in men and £17464.3 in women, which was
not signiﬁcantly different from those who walked <1h
per day (men: £16650.0, p¼0.7315; women: £17742.9,
p¼0.8330).
Baseline characteristics in terms of categories for time
spent walking
Table 1 shows the baseline characteristics of the study
participants according to the categories of time spent
walking for men and women, respectively.
As compared with those who walked <1 h per day,
participants who walked $1 h per day were less likely to
be smokers and obese. Self-reported histories of hyper-
tension, diabetes mellitus and liver disease were all
signiﬁcantly less prevalent in those who walked $1 h per
day.
Mortality in terms of categories for time spent walking
Figure 1A (for men) and Figure 1B (for women) show
the multiadjusted mortality (per 1000) in each of the age
groups according to the categories of time spent
walking.
In men in each age group, the multiadjusted mortality
was lower in participants who walked $1 h per day than
in those who walked <1 h per day. In women in all age
groups except for the aged 40e44 and 45e49 year
groups, the multiadjusted mortality was lower in partic-
ipants who walked $1 h per day than in those who
walked <1 h per day.
Nagai M, Kuriyama S, Kakizaki M, et al. BMJ Open 2011;2:e000240. doi:10.1136/bmjopen-2011-000240 3
Walking and life expectancy and lifetime medical costTable 2 shows the mortality ratio with 95% CIs
according to the categories of time spent walking. In men,
the multiadjusted mortality ratio for participants who
walked $1 h per day was signiﬁcantly lower than that for
participants who walked <1 h per day (0.90, 95% CI 0.82
to 0.98, p¼0.0153). In women, the multiadjusted mortality
ratio for participants who walked $1 h per day was non-
signiﬁcantly lower than that for participants who walked
<1 h per day (0.95, 95% CI 0.82 to 1.10, p¼0.4693).
Life expectancy and lifetime medical expenditure in terms
of time spent walking
Table 3 shows the life expectancy and lifetime medical
expenditure from 40 years of age with 95% CIs
according to the categories of time spent walking.
In men, the multiadjusted life expectancy of those who
walked $1 h per day was 44.81 years (95% CI 43.66 to
45.94), which was signiﬁcantly longer by 1.38 years
(p¼0.0073) than for those who walked <1 h per day
(43.43 years; 95% CI 42.39 to 44.41). In women, the
same results were observed, although the differences did
not reach statistical signiﬁcance.
In spite of their longer life expectancy, their lifetime
medical expenditure from 40 years of age was signiﬁ-
cantly lower in men and non-signiﬁcantly lower in
women. The multiadjusted lifetime medical expendi-
ture for participants who walked $1 h per day was
£99423.6 (95% CI 92515.9 to 106694.7), signiﬁcantly
lower by 7.6% (p¼0.0048) than for those who walked
<1h p e r d a y ( £107544.2; 95% CI 101234.0 to
114044.6). In women, the multiadjusted lifetime
medical expenditure for participants who walked $1h
per day was £128161.2 (95% CI 111335.0 to 148494.7),
non-signiﬁcantly lower by 2.7% (p¼0.2559) than for
Table 1 Baseline characteristics by time-spent-walking categories in 27738 participants
Men Women
Time spent walking Time spent walking
<1h ‡1 h p Value* <1h ‡1 h p Value*
No of subjects 7363 8158 0.2784 6303 5914 0.0714
Mean (SD) age 57.4 (10.6) 57.2 (10.2) 57.9 (10.1) 57.6 (9.7)
Smoking status (%)
Current and past smoker 81.9 79.8 0.0011 12.6 9.9 <0.0001
Never smoker 18.1 20.2 87.5 90.1
Alcohol drinking (%)
Never and past drinker 26.5 25.1 0.1117 74.7 75.4 0.1380
Current drinker,
1e449 g/week
61.3 62.2 24.3 23.9
Current drinker,
$450 g/week
12.2 12.8 1.1 0.7
Body mass index (%)
<21 kg/m
2 18.5 20.5 <0.0001 18.6 19.4 0.0019
21e24.9 kg/m
2 53.3 55.8 50.7 52.9
$25 kg/m
2 28.3 23.7 30.7 27.7
Self-rated health (%)
Good 73.1 79.3 <0.0001 72.5 78.2 <0.0001
Not good 26.9 20.7 27.5 21.8
Sports and physical activity (%)
$3 h/week 13.2 18.7 <0.0001 10.7 16.6 <0.0001
<3 h/week 86.8 81.3 89.3 83.4
History of hypertension (%)
Presence 21.5 18.6 <0.0001 24.2 20.1 <0.0001
Absence 78.5 81.4 75.8 79.9
History of diabetes mellitus (%)
Presence 7.4 4.8 <0.0001 5.1 3.2 <0.0001
Absence 92.6 95.2 94.9 96.8
History of cancer (%)
Presence 2.1 1.8 0.2563 2.8 2.8 0.9032
Absence 97.9 98.2 97.2 97.2
History of liver disease (%)
Presence 6.9 5.7 0.0013 3.7 2.9 0.0223
Absence 93.1 94.4 96.3 97.1
History of kidney disease (%)
Presence 2.9 2.7 0.3493 3.6 2.7 0.0049
Absence 97.1 97.3 96.4 97.3
*p Values were calculated using the c
2 test.
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115902.4 to 150714.3).
DISCUSSION
The present results indicate that the multiadjusted life-
time medical expenditure from the age of 40 years for
those who walked $1 h per day was signiﬁcantly lower by
7.6% in men and non-signiﬁcantly lower by 2.7% in
women than for those who walked <1 h per day. This
decrease in lifetime medical expenditure was observed
in spite of a longer life expectancy (1.38 years for men
and 1.16 years for women) among those who walked
$1 h per day. Thus, a healthy lifestyle not only extended
longevity but also decreased the amount of lifetime
medical expenditure, especially men.
We observed statistically signiﬁcant differences for
men but not for women. Although the differences did
not reach statistical signiﬁcance, the same results were
observed for women. The reason why the impact of
walking was smaller in women than in men was
unknown. In women, other factors such as obesity and
postmenopausal change might have a stronger impact
on life expectancy and lifetime medical expenditure
than walking.
Comparison with other studies
Four studies have addressed the association between
physical activity level and life expectancy.
1e4 Addition-
ally, studies investigating associations between time spent
walking,
5e13 or distance walked
17 18 and mortality have
consistently shown that participants who have a higher
physical activity have a longer life expectancy and lower
mortality than participants who have a lower physical
activity. Only one study has reported the association
between physical activity and lifetime medical expendi-
ture.
4 In a simulation study, Keeler et al demonstrated
that if participants with a sedentary lifestyle had exer-
cised regularly, the additional exercise would have
increased their life expectancy by 300 days and saved
£1900 in lifetime costs. Even though there is a difference
between physical activity and walking, this result is
consistent with the present ﬁnding that participants who
walked $1 h per day lived longer and had a lower life-
time medical expenditure.
We previously calculated life expectancy and lifetime
medical expenditure in relation to smoking and BMI
from age 40 years using the same dataset as that for the
present study.
24 The results indicated that lifetime
medical expenditure was lower for smokers than for
non-smokers, reﬂecting the 3.5-year shorter life expec-
tancy of smokers.
24 On the other hand, lifetime medical
expenditure was higher for participants who were obese
(BMI$30.0) than for those who were of normal weight
(18.5#BMI<25.0), even though the former lived 2 years
less than the latter (Nagai M, Kuriyama S, Kakizaki M,
et al. Impact of obesity, overweight and underweight on
life expectancy and lifetime medical expenditures. Popul
Health Metr, under review). In fact, both smokers and
obese participants had a shorter life expectancy than
non-smokers and normal-weight participants, whereas
Figure 1 Multiadjusted mortality by time-spent-walking categories in each age group in (A) men and (B) women.
Table 2 Mortality ratio for time-spent-walking categories in 27738 participants
Univariate Multiadjusted*
Time spent walking Mortality ratio (95% CI) p Value Mortality ratio (95% CI) p Value
Men <1 h 1.00 1.00
$1 h 0.87 (0.80 to 0.94) 0.0009 0.90 (0.82 to 0.98) 0.0153
Women <1 h 1.00 1.00
$1 h 0.89 (0.77 to 1.03) 0.1135 0.95 (0.82 to 1.10) 0.4693
*Adjusted for age groups, smoking status, alcohol drinking, body mass index, self-rated health, sports and physical activity, and history of
hypertension, diabetes mellitus, cancer, liver disease and kidney disease.
Nagai M, Kuriyama S, Kakizaki M, et al. BMJ Open 2011;2:e000240. doi:10.1136/bmjopen-2011-000240 5
Walking and life expectancy and lifetime medical costtheir lifetime medical expenditure was conversely
increased. These differences could be explained by the
impact of these risk factors on quality of life. Using
prospective data for 16176 adult Caucasians in the
USA,
31 Reuser et al estimated life expectancy and years of
life with and without activities of daily-living disability in
relation to smoking and BMI, respectively. The results
indicated that smoking decreased both life expectancy
and years of life with activities of daily-living disability,
whereas obesity decreased the former but increased the
latter, thus leading to the conclusion that ‘smoking kills,
and obesity disables’. Reuser’s conclusion is concordant
with the impact of walking on life expectancy and life-
time medical expenditure. Physical activity decreases not
only mortality but also disability,
5e13 17 18 32 leading to
lower medical expenditure.
33 For instance, walking has
been signiﬁcantly associated with a lower risk of cardio-
vascular disease,
7 stroke,
34 coronary heart disease,
35 36
type 2 diabetes
37 and hypertension.
38 Consequently,
walking also reduces expenditure on medication needed
for these conditions.
39
Strengths and limitations
This is the ﬁrst study to have investigated the association
between walking, life expectancy and lifetime medical
expenditure. A major strength of this study was that we
collected individual data on medical expenditure based
on a cohort study of survival and medical-care utilisation,
and its cost, for all participants,
19 22 24 28 and the NHI
covers almost all medical treatment in Japan. Second, we
conducted a 13-year prospective observation of 27738
Japanese adults aged 40e79 years living in the commu-
nity who were free of any functional limitations or
chronic conditions interfering with physical activity, with
an accrued total of 285342 person-years. Third, in order
to reduce bias or reverse causation in that people did not
walk because of functional limitations that also required
medical expenditure, we excluded participants who, at
the baseline, reported limited physical function or
conditions interfering with physical activity. Additionally,
to control for confounders, we also included various
covariates in our Poisson regression model and linear
regression model.
On the other hand, several limitations should also be
considered. First, we assessed walking using a simple
questionnaire in which we asked the participants to
report only the time spent walking and did not ask about
walking pace, distance walked or any distinction between
walking for exercise and other reasons. Second, a longer
time spent walking may be a reﬂection of performing
more vigorous activity, making it difﬁcult to distinguish
the impact of walking from other types of physical
activity. However, the present result did not change after
multivariate adjustment.
Conclusions and policy implication
In summary, lifetime medical expenditure was shown to
be decreased in participants who walked $1 h per day,
despite the fact that they lived longer. Increased
longevity resulting from a healthier lifestyle did not
necessarily translate into an increased amount of
medical expenditure throughout life. However, in the
present study, around 50% of study participants walk
<1 h per day. To increase their walking time, the
recommendation of walking with a pedometer may be
useful.
40 An increase in walking time at the population
level would bring about a tremendous change in
people’s health and medical cost. A campaign to
encourage people to walk for longer and a program to
make walking environments safer and more pleasant
Table 3 Life expectancy and lifetime medical expenditure at age 40 years for time-spent-walking categories in 27738
participants
Time
spent walking
Univariate Multiadjusted*
Estimate 95% CI p Value Estimate 95% CI p Value
Men Life expectancy (years) at age 40 years
<1 h 42.41 41.45 to 43.26 0.0004 43.43 42.39 to 44.41 0.0073
$1 h 44.19 43.15 to 45.19 44.81 43.66 to 45.94
Lifetime medical expenditure (₤) at age 40 years
<1 h 107023.2 101093.6 to
113066.3
<0.0001 107544.2 101234.0 to
114044.6
0.0048
$1 h 94402.1 87812.3 to
101248.0
99423.6 92515.9 to
106694.7
Women Life expectancy (years) at age 40 years
<1 h 52.25 49.79 to 54.92 0.0569 56.62 53.17 to 60.62 0.2351
$1 h 54.25 51.38 to 57.48 57.78 54.02 to 62.22
Lifetime medical expenditure (₤) at age 40 years
<1 h 123553.0 111619.5 to
137549.6
0.0644 131766.8 115902.4 to
150714.3
0.2559
$1 h 115896.0 102406.6 to
131792.1
128161.2 111335.0 to
148494.7
*Adjusted for age groups, smoking status, alcohol drinking, body mass index, self-rated health, sports and physical activity, and history of
hypertension, diabetes mellitus, cancer, liver disease and kidney disease as same as table 2.
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life expectancy without apparently increasing lifetime
medical expenditure, especially for men.
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